Hydroxychloroquine Naysayers have Financial Ties to Remdesivir Developer
This is an excellent exposé from former CBS investigative journalist, Sharyl Attkisson, who discusses the prophylactic and treatment efficacy of hydroxychloroquine as well as Gilead Science’s newly developed drug, Remdesivir, with several physicians.
It turns out that many of those disparaging the use of hydroxychloroquine, a very inexpensive drug that has been used for many decades, have ties to Gilead Science. Janet Levy Ross
Watch the video below for more information.
Comments are closed.
